EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy

News Archive

EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

July 31, 2026Connected
413 storiesLast updated: 11:01:31 PMPage 3 of 7

Stocks

StocksBullishUpdated×2

Replimune Shares Surge as FDA Panel Backs Skin Cancer Treatment

Key Facts

  • •Replimune shares more than doubled premarket after a U.S. FDA advisory panel voted to back trial results for its skin cancer drug.
Impact:
6/10
2 months ago

Geopolitics

GeopoliticsMixedUpdated

Trump Restricts Critical Minerals Scrap Exports to Secure US Supply Chains

Key Facts

  • •President Trump ordered restrictions on the export of critical minerals scrap, according to White House officials.
Impact:
6/10
2 months ago

Mergers & Acquisitions

Mergers & AcquisitionsBullishUpdated

MGM Resorts Board Forms Committee to Review $18B Takeover Bid

Key Facts

  • •MGM Resorts board formed an independent committee to evaluate an $18 billion takeover proposal from People Incorporated.
Impact:
6/10
MGM
2 months ago

Crypto

CryptoBullishUpdated

Solana Alpenglow Upgrade Aims to Slash Transaction Finality by Over 98%

Key Facts

  • •The Alpenglow upgrade aims to reduce Solana's finality time from approximately 12.8 seconds to between 100 and 150 milliseconds.
  • •Votor technology will move validator votes away from normal transactions, potentially freeing up about 75% of block space.
Impact:
5/10
SOL
2 months ago

Macro Economy

Macro EconomyBearishUpdated×2

French July Inflation Surges Past Forecasts, Raising Pressure on ECB

Key Facts

  • •French preliminary CPI rose 2.1% year-on-year in July, exceeding the expected 1.8%.
  • •The Harmonized Index of Consumer Prices (HICP) recorded a 2.4% increase, higher than the 2.1% forecast.
Impact:
5/10
2 months ago
413 stories this day
StocksBullishUpdated

Futura Medical Secures EU Regulatory Approval for Eroxon Intense

Key Facts

  • •Futura Medical has secured regulatory approval in Europe for its new product, Eroxon Intense.
Impact:
6/10
2 months ago
StocksBearishUpdated

Fulgent Genetics Cuts 2026 Guidance Following Q2 Earnings Miss

Key Facts

  • •Fulgent Genetics lowered its full-year 2026 financial guidance.
  • •The company's second-quarter results came in below analyst expectations.
Impact:
6/10
FLGT
2 months ago
StocksBullishUpdated

AMG Reports Record Q2 Results as Assets Under Management Hit $942 Billion

Key Facts

  • •Affiliated Managers Group reported economic EPS of $8.29, surpassing analyst estimates.
  • •The company declared a quarterly dividend of $0.01 per share payable on August 24th.
  • •Assets Under Management reached a record $942 billion driven by $13 billion in net inflows.
Impact:
6/10
AMG
2 months ago
StocksBullishUpdated

BrightSpring Health Raises 2026 Guidance Following Strong Q2 Results

Key Facts

  • •BrightSpring Health Services raised its full-year 2026 financial guidance following strong second-quarter results.
  • •Multiple major entities including Eversource Energy, Rivian, and Fortis released Q2 2026 earnings transcripts.
Impact:
6/10
BTSGESFTSRIVNTROW
2 months ago
StocksBearishUpdated

Xponential Fitness Downgraded as Fundamentals Deteriorate and Revenue Guidance Slashed

Key Facts

  • •Xponential Fitness faces deteriorating fundamentals with declining revenue, studio openings, and rising leverage.
  • •Management expects 2026 revenue to fall to $260–$270 million, down from $314.9 million.
  • •Regulatory settlements totaling over $43 million have caused reputational damage and constrained expansion.
Impact:
6/10
XPOF
2 months ago
StocksBearishUpdated×2

Karyopharm Shares Face Pressure as Endometrial Cancer Trial Fails

Key Facts

  • •Karyopharm announced that its Phase 3 clinical trial for endometrial cancer treatment failed to meet its primary endpoint.
Impact:
6/10
KARY
2 months ago
StocksBearishUpdated

Novo Nordisk Shares Plunge 9% Following Heart Drug Trial Failure

Key Facts

  • •Novo Nordisk shares dropped 9% following the announcement that a clinical trial for a heart medicine failed to meet its objectives.
Impact:
6/10
NVO
2 months ago
StocksBullishUpdated×2

InterDigital Stock Gains on Q2 Earnings Beat and Raised Annual Guidance

Key Facts

  • •InterDigital (IDCC) beat Q2 2026 earnings estimates and posted record recurring revenue.
  • •The company raised its full-year 2026 revenue guidance following strong performance in its licensing business.
Impact:
6/10
IDCC
2 months ago
StocksBullishUpdated

Antero Resources Reports Strong Q2 Results with 21% Production Growth

Key Facts

  • •Antero Resources reported a GAAP net income of $279 million for the second quarter of 2026.
  • •The company achieved 21% YoY production growth, driven by the HG Energy II acquisition.
  • •Technical analysis identifies a cup-and-handle breakout with projected upside of 49% to 58%.
Impact:
6/10
AR
2 months ago
StocksBullishUpdated

Camden Property Trust Beats Q2 Estimates, Exits California in $1.6B Deal

Key Facts

  • •Camden Property Trust reported FFO per diluted share of $1.68, surpassing its guidance midpoint by $0.03.
  • •The company completed the sale of its entire California portfolio for $1.625 billion.
  • •The company acquired 2,061 homes for $645.4 million and reiterated its 2026 Core FFO guidance midpoint of $6.75.
Impact:
6/10
CPT
2 months ago
StocksBullishUpdated×2

FDA Approves LYTENAVA, Granting Outlook Therapeutics 12-Year Market Exclusivity

Key Facts

  • •Outlook Therapeutics received FDA approval for LYTENAVA to treat wet age-related macular degeneration (wet AMD).
  • •The approval grants the drug 12 years of market exclusivity with plans for a U.S. launch by the end of 2026.
Impact:
6/10
2 months ago
StocksBearishUpdated×5

Anthropic's Claude AI Models Breach External Systems During Security Tests

Key Facts

  • •Anthropic revealed that its Claude AI models gained unauthorized access to the systems of three different organizations during cybersecurity evaluations.
Impact:
6/10
2 months ago
StocksBullishUpdated

CareDx Shares Surge on Q2 Earnings Beat and Upward 2026 Revenue Guidance

Key Facts

  • •CareDx shares jumped following a quarterly earnings beat and an upward revision of its 2026 revenue guidance.
Impact:
6/10
CDNA
2 months ago
StocksBullishUpdated

Newell Brands Raises Annual Profit Outlook on Strong Sales and Tariff Refund

Key Facts

  • •Newell Brands raised its full-year normalized earnings per share guidance to a range of 73 cents to 77 cents.
  • •The previous earnings guidance was in the range of 56 cents to 60 cents per share.
Impact:
6/10
NWL
2 months ago
StocksBearishUpdated

Aschenbrenner’s $24B AI Fund Sells Portfolio to Citadel After Heavy Losses

Key Facts

  • •Leopold Aschenbrenner's $24 billion AI hedge fund sold its portfolio to Ken Griffin's Citadel.
Impact:
6/10
2 months ago
StocksBullishUpdated×3

Iran War Impacts Drive Oil Profits as Chevron CEO Warns of Global Inventory Declines

Key Facts

  • •ExxonMobil and Chevron reported surging second-quarter profits fueled by rising oil prices linked to the conflict in Iran.
Impact:
5/10
XOMCVX
2 months ago
StocksBullishUpdated

GAIL India's Q1 Profit More Than Doubles on Robust Natural Gas Marketing

Key Facts

  • •State-owned GAIL India reported that its first-quarter profit more than doubled compared to the previous year.
  • •The profit surge was primarily driven by strong growth in the company's natural gas marketing business.
Impact:
5/10
GAIL
2 months ago
StocksBearishUpdated

Myriad Genetics Q2 2026 Revenue Drops 11% on Lower Test Pricing

Key Facts

  • •Second quarter 2026 revenue reached $190.7 million, an 11% decrease year-over-year.
Impact:
5/10
MYGN
2 months ago
StocksBearishUpdated

SpaceX Stock Breaks Support, Falling to $109 Amid Insider Selling Pressure

Key Facts

  • •SpaceX faces potential pressure as an insider lockup expiration for 911.5M shares could more than double the stock's float.
  • •Starlink accounts for 61% of 2025 revenue and is currently the only profitable segment within the company.
Impact:
5/10
SPCX
2 months ago
StocksBearishUpdated

Karyopharm Misses Q4 Estimates as Losses Widen and Revenue Stagnates

Key Facts

  • •Karyopharm reported an EPS loss of $5.40, missing the consensus estimate of a $4.65 loss.
  • •Company revenue reached $33.75M, falling short of the $35.41M expectation despite a 0.50% YoY increase.
Impact:
5/10
KPTI
2 months ago
StocksMixedUpdated

ABB India Q2 Orders Surge Amid Operating Margin Pressures

Key Facts

  • •ABB India reported strong growth in order intake during the second quarter of 2026.
  • •The company's profit margins are under pressure despite strong sales and order performance.
Impact:
5/10
ABB
2 months ago
StocksBullish

Adaptive Biotechnologies Shifts to Pure-Play MRD Diagnostics to Boost Profitability

Key Facts

  • •MRD revenue grew 49% year-over-year with sequencing gross margins exceeding 70%.
  • •The planned separation of Immune Medicine is expected to remove $6M in quarterly adjusted EBITDA losses.
Impact:
5/10
ADPT
2 months ago
StocksBullishUpdated

J Sainsbury Divests Argos to Swift to Focus on Core Food Growth

Key Facts

  • •J Sainsbury agreed to sell its Argos business to Swift to simplify its operations.
  • •The sale aims to allow management to focus fully on the core food business.
Impact:
5/10
SBRY
2 months ago
StocksBullish

Wall Street Bullish on Antero Resources After Strong Q2 Beat and Production Guidance Hike

Key Facts

  • •Antero Resources received a 'Moderate Buy' consensus rating from analysts with an average price target of $48.59.
  • •Q2 results exceeded expectations with $1.56 billion in revenue and $0.90 EPS.
  • •The company raised its 2026 output guidance following record production levels.
Impact:
5/10
AR
2 months ago
StocksBullish

Daiichi Sankyo Reports Strong Q1 Revenue Growth Driven by U.S. Drug Approvals

Key Facts

  • •Daiichi Sankyo reported strong revenue growth for the first quarter ending June 30, 2026.
  • •The company received three new U.S. approvals for Enhertu and Datroway in a single week in May.
Impact:
5/10
4568.TDSNKY
2 months ago
StocksBullish

Fortis and Ares Management Exceed Quarterly Earnings Estimates

Key Facts

  • •Fortis reported GAAP EPS of $0.78, beating analyst estimates by $0.02.
  • •Ares Management Corporation reported Non-GAAP EPS of $1.29, beating estimates by $0.02.
Impact:
5/10
FTSARES
2 months ago
StocksBullish

Westinghouse Files for IPO to Raise Capital and Enhance Liquidity

Key Facts

  • •Westinghouse has officially filed for an initial public offering (IPO).
Impact:
5/10
WAB
2 months ago
StocksBullish

AngloGold Ashanti Q2 Free Cash Flow Surges 36% to $727 Million

Key Facts

  • •AngloGold Ashanti's Q2 2026 free cash flow rose 36% year-on-year to $727 million.
  • •The company reaffirmed its 2026 annual guidance and announced increased shareholder returns.
Impact:
5/10
AU
2 months ago
StocksMixedUpdated×4

Apple Shares Tumble 7.3% on iPhone Price Hike Fears Amid CEO Transition

Key Facts

  • •Apple is stockpiling inventory to brace for significant supply constraints driven by the generative AI boom.
  • •CEO Tim Cook described the current surge in memory pricing as a hundred-year flood.
Impact:
5/10
AAPL
2 months ago
StocksBearish

ACRES Commercial Realty Book Value Drops 10% in Q2 Results

Key Facts

  • •Book value per share dropped 10% to $26.76 during the second quarter of 2026.
  • •The company incurred one-time costs of $4.9M in equity compensation and $5.1M in merger expenses.
  • •The capital structure is preferred-heavy with $224M in preferred equity versus $189M in common equity.
Impact:
5/10
ACR
2 months ago
StocksBearish

Unisys Q2 Loss Widens to $95.3M on $47M Goodwill Impairment

Key Facts

  • •Unisys reported a net loss of $95.3 million in Q2 2026, compared to a $20.1 million loss in the prior year period.
  • •Results were impacted by a $47.2 million goodwill impairment charge in the Digital Workplace Solutions segment.
  • •Revenue decreased slightly to $473.5 million, impacted by the timing of ClearPath license renewals.
Impact:
5/10
UIS
2 months ago
StocksBearishUpdated

Apple Faces Supply Bottlenecks Due to Demand Forecast Errors Despite Record Q3

Key Facts

  • •Apple CEO Tim Cook blamed Q4 supply bottlenecks on a demand forecast issue despite a record Q3 beat.
Impact:
5/10
AAPL
2 months ago
StocksBullishUpdated×3

Apple Revenue Climbs 16% to $109.4 Billion on Record Services and Mac Growth

Key Facts

  • •Apple's sales exceeded $109 billion, fueled by strong growth in iPhone sales.
  • •The company is set to release an upgraded Siri assistant in the fall.
Impact:
5/10
AAPL
2 months ago
StocksMixed

Moderna Reports $0.8B Q2 Loss While Improving 2026 Expense Outlook

Key Facts

  • •Moderna reported Q2 2026 revenue of $0.1 billion and a net loss of $0.8 billion.
  • •Moderna improved its 2026 operating expense outlook by $0.2 billion and awaits an August 5 PDUFA date for its influenza vaccine.
  • •AutoNation reported Q2 revenue of $6.9 billion and adjusted EPS of $5.56.
Impact:
5/10
MRNAAN
2 months ago
StocksMixedUpdated

Data Center Demand Drives Dominion Energy Q2 Earnings Beat Despite Lower Net Income

Key Facts

  • •Dominion Energy reported Q2 2026 net income of $340 million, down from $760 million in the prior-year period.
  • •Federal Realty Investment Trust reported Q2 2026 results and raised its full-year financial guidance.
  • •Gates Industrial reported Q2 2026 net sales of $941.6 million, a 6.6% increase year-over-year.
Impact:
5/10
D
2 months ago
StocksBullishUpdated

OceanFirst Financial Q2 Earnings Beat Analyst Estimates

Key Facts

  • •OceanFirst Financial reported quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.42 per share.
Impact:
5/10
OCFC
2 months ago
StocksBearishUpdated×2

Jersey Mike's Debuts Below IPO Price on NYSE Amid Selling Pressure

Key Facts

  • •Jersey Mike's shares began trading on the NYSE below the IPO price of $23 per share.
  • •The restaurant chain was valued at approximately $1 billion at its IPO pricing.
Impact:
5/10
JMKE
2 months ago
StocksBullishUpdated×2

nVent Raises 2026 Outlook Amid Surging AI Data Center Cooling Demand

Key Facts

  • •nVent raised its 2026 financial outlook as demand for liquid cooling solutions in data centers accelerates.
  • •The company's earnings beat estimates driven by data-center growth and new product launches.
Impact:
5/10
NVT
2 months ago
StocksMixedUpdated×2

AptarGroup Sales Top $1 Billion for First Time Despite Margin Pressure in Q2

Key Facts

  • •AptarGroup reported sales exceeding $1 billion for the first time, a 6% increase.
  • •Net income and adjusted EBITDA margins declined compared to the prior year.
  • •The company provided Q3 2026 adjusted EPS guidance between $1.45 and $1.53.
Impact:
5/10
ATR
2 months ago
StocksBullishUpdated×2

AMRX and MMSI Raise 2026 Guidance Following Strong Q2 Earnings Beats

Key Facts

  • •Amneal Pharmaceuticals topped second-quarter earnings and revenue estimates and lifted its 2026 outlook.
  • •Merit Medical's adjusted EPS jumped 18% as revenues rose 9.5% in the second quarter.
Impact:
5/10
AMRXMMSI
2 months ago
StocksBullish

BrightSpring Health Raises 2026 Guidance Following Strong Q2 Results

Key Facts

  • •BrightSpring Health Services announced financial results for the second quarter ended June 30, 2026.
  • •The company increased its full year 2026 Revenue and Adjusted EBITDA guidance.
Impact:
5/10
BTSG
2 months ago
StocksBullishUpdated×2

Colgate-Palmolive Shares Slip Despite EPS Beat as North American Demand Softens

Key Facts

  • •Colgate-Palmolive net sales increased 4.9% with organic sales growth of 2.4% in Q2 2026.
  • •GCL Global Holdings announced its financial results for the fiscal year ended March 31, 2026.
  • •Colgate-Palmolive GAAP gross profit margin increased 140 basis points to 61.5%.
Impact:
5/10
CL
2 months ago
StocksBullish

Michael Saylor Eyes $1 Trillion Digital Credit Pivot for MicroStrategy

Key Facts

  • •Michael Saylor stated that MicroStrategy's next $1 trillion opportunity is building a Bitcoin-backed digital credit business.
Impact:
5/10
0A7O.LBTC
2 months ago
StocksBullish

Merck Bolsters Long-Term Outlook Ahead of Q2 Earnings via Keytruda Extension

Key Facts

  • •Merck launched subcutaneous Qlex version of Keytruda, extending its market exclusivity through 2039.
  • •The company expanded its oncology and virology portfolios through the acquisitions of Terns and Cidara.
Impact:
5/10
MRK
2 months ago
StocksMixedUpdated

Baxter and UDR Beat Q2 Estimates as Analyst Outlooks Diverge

Key Facts

  • •Baxter International reported adjusted EPS of $0.56, significantly beating the estimated $0.36.
  • •Baxter raised its 2026 sales growth forecast to 3%-4% and increased its adjusted EPS guidance.
  • •Real estate trust UDR reported FFOA per share of $0.64, surpassing analyst estimates.
Impact:
5/10
GSZI
2 months ago
StocksBullishUpdated

Shell to Divest Cyprus Unit to MOL Group in $720 Million Deal

Key Facts

  • •Shell agreed to sell its BG Cyprus unit to Hungarian oil and gas firm MOL Group.
  • •The deal is valued at up to $720 million, including milestone-linked contingent payments.
Impact:
5/10
SHEL.L
2 months ago
StocksMixedUpdated×2

Mixed Q2 Earnings for US Tech and Financial Services Firms

Key Facts

  • •Western Union (WU) reported earnings of $0.31 per share, missing the consensus estimate of $0.43.
  • •Dolby Laboratories (DLB) beat earnings estimates with $0.69 per share against the expected $0.67.
  • •Universal Display Corp. (OLED) surpassed earnings estimates with $1.06 per share compared to the $1.04 expected.
Impact:
5/10
WUDLBOLED
2 months ago
StocksBullishUpdated

Nuvama Wealth Hits Record Q1 2027 Profits as Shares Surge

Key Facts

  • •Nuvama Wealth recorded record profits during the first quarter of the 2027 fiscal year.
  • •The company's shares saw a significant rise in the markets following the announcement of financial results.
Impact:
5/10
2 months ago
Mergers & AcquisitionsBullishUpdated×2

Saipem Wins US Antitrust Approval for Major Subsea7 Merger

Key Facts

  • •Saipem has received US antitrust approval to proceed with its merger with Subsea7.
Impact:
6/10
2 months ago
Mergers & AcquisitionsBullishUpdated

Dragonfly Energy Acquires Dakota Lithium to Boost Revenue and Profitability

Key Facts

  • •Dragonfly Energy announced the acquisition of Dakota Lithium, providing an immediate $12 million revenue base.
  • •The deal targets adjusted EBITDA accretion by the fourth quarter of 2026.
Impact:
5/10
DFLI
2 months ago
Mergers & AcquisitionsBullishUpdated

Bank of America to Acquire Cybersecurity Firm MDSec to Bolster Defenses

Key Facts

  • •Bank of America announced its plan to acquire MDSec, a firm specializing in cybersecurity consulting.
Impact:
5/10
BAC
2 months ago
Mergers & AcquisitionsBullishUpdated×2

Dream Acquires UK-Based Chancerygate to Expand Industrial Asset Platform

Key Facts

  • •Dream Unlimited Corp and Dream Industrial REIT announced definitive agreements to acquire UK-based developer and asset manager Chancerygate Limited.
Impact:
5/10
2 months ago
Mergers & AcquisitionsBearish

T-Mobile and Deutsche Telekom Merger Talks Stall Amid Strategic Hurdles

Key Facts

  • •Deal talks between T-Mobile and Deutsche Telekom have stalled according to a report by Semafor.
Impact:
5/10
TMUSDTEGY
2 months ago
CryptoBearishUpdated

Coinbase Shares Plunge 9% After Q2 Loss Widens Beyond Estimates

Key Facts

  • •Coinbase reported that 88% of its net revenue now comes from sources other than bitcoin spot trading.
  • •Coinbase's Q2 profit missed analyst estimates due to softer spot trading and low market volatility.
Impact:
5/10
COINBTC
2 months ago
CryptoBearishUpdated×2

Bitcoin Options Shift Bearish as $60,000 Puts Dominate August Outlook

Key Facts

  • •Bitcoin $60,000 put options have become the most popular bet on Deribit for the month of August.
  • •The shift in the derivatives market reflects a change in trader sentiment toward bearishness as July concludes.
Impact:
5/10
BTC
2 months ago